Showing results (21-30 of 133) with videos related to
Sort By:
Pageof 14
The Journal of Rheumatology. Supplement|November 3, 2011
Quality of life issues in pediatric immune-mediated inflammatory diseaseCiarán M Duffy, George A Wells, Anthony S Russell, et al.BMC Musculoskeletal Disorders|November 19, 2011
Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): results from the CanACT studyBoulos Haraoui, Alfred Cividino, Jacqueline Stewart, et al.Rheumatology and Therapy|October 30, 2018
Real-World Tocilizumab Use in Patients with Rheumatoid Arthritis in Canada: 12-Month Results From an Observational, Noninterventional StudyBoulos Haraoui, Shahin Jamal, Vandana Ahluwalia, et al.The Journal of Rheumatology|April 3, 2012
Treating rheumatoid arthritis to target: a Canadian physician surveyBoulos Haraoui, William Bensen, Louis Bessette, et al.Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 5, 2013
Biologics and the cardiovascular system: a double-edged swordCamille Roubille, Johanne Martel-Pelletier, Boulos Haraoui, et al.Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 5, 2013
Cardiovascular adverse effects of anti-inflammatory drugsCamille Roubille, Johanne Martel-Pelletier, Jean-Marc Davy, et al.The Journal of Rheumatology. Supplement|November 3, 2011
Validity of quality of life measurement tools--from generic to disease-specificGeorge A Wells, Anthony S Russell, Boulos Haraoui, et al.The Journal of Rheumatology|December 3, 2013
Clinical, functional, and radiographic implications of time to treatment response in patients with early rheumatoid arthritis: a posthoc analysis of the PREMIER studyEdward C Keystone, Boulos Haraoui, Benoît Guérette, et al.Arthritis Research & Therapy|September 27, 2023
Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abataceptLouis Bessette, Boulos Haraoui, Emmanouil Rampakakis, et al.The Journal of Rheumatology|October 17, 2007
Advantages and limitations of utility assessment methods in rheumatoid arthritisAriel Beresniak, Anthony S Russell, Boulos Haraoui, et al.Pageof 14